Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Distribution of 5-aminolevulinic acid-derived fluorescence in basal cell carcinoma skin tumors
RBR-5hkxkjhPhase 2Recruiting
- Sponsor
- Universidade de São Paulo
- Start
- Apr 2026
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of methyl aminolevulinate and 5-aminolevulinic acid in basal cell carcinoma (BCC) (12 arms), sponsored by Universidade de São Paulo. Started Apr 2026; status: recruiting.
02
Drugs
methyl aminolevulinate5-aminolevulinic acid
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on RBR-5hkxkjh.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5hkxkjh.